Evidence map›Paper›PMID 39847323›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Enhancing drug solubility through competitive adsorption on silica nanosurfaces with ultrahigh silanol densities.

Zhuo Xu, Changliang Zhu, Hongchuan Shen, Yuan Liu, Jiashen Tang, David A Weitz, Lei Xu

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhuo XuPharmaEase Tech Limited, Sheung Wan, Hong Kong, China.ORCID 0009-0008-4142-7912
Changliang ZhuThe Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.ORCID 0000-0002-4180-123X
Hongchuan ShenThe Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.ORCID 0000-0002-4194-2366
Yuan LiuThe Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.
Jiashen TangThe Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.ORCID 0000-0002-2763-6194
David A WeitzPharmaEase Tech Limited, Sheung Wan, Hong Kong, China.ORCID 0000-0001-6678-5208
Lei XuPharmaEase Tech Limited, Sheung Wan, Hong Kong, China.ORCID 0000-0001-9229-586X

Funding

Innovation and Technology Commission (ITC) Health@InnoHKInnovation and Technology Commission (ITC) TSSSU/CUHK/24/07/1
6 · The paper itself

Abstract

We develop a technology based on competitive adsorption between drug molecules and water, specifically designed to address the critical issue of poor drug solubility. By specially engineering silica nanosurfaces with ultrahigh densities of silanol, we significantly enhance their affinity for both drug molecules and water, with a notably greater increase in water affinity. Such surfaces can effectively adsorb a variety of drug molecules under dry conditions. Upon exposure to water, these surfaces preferentially bind to water molecules, initiating a competitive adsorption process with the drug molecules. This competitive process turns water molecules from obstacles into catalysts for drug dissolution by actively displacing drug molecules from the surface, causing their rapid desorption and potentially enhancing their solubility by two to three orders of magnitude. The method is general, applicable to a wide array of drugs, stable for long-time storage, cost-effective, and scalable for mass production. Consequently, it has the potential to emerge as a next-generation platform for drug formulation and delivery.

Indexed as

NanostructuresSilanesSilicon DioxideAdsorptionPharmaceutical PreparationsSolubilitySurface PropertiesWaterPharmaceutical PreparationsSilanessilanolSilicon DioxideWatercompetitive adsorptiondrug deliverysilica nanosurfacesolubility enhancementultrahigh silanol density

Identifiers

PMID39847323
PMCPMC11789088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.